[1]
Benameur, H. Enteric capsule drug delivery technology—Achieving protection without coating. Drug Des. Deliv., 2015, 15, 34-37.
[5]
Sydow, G.; Sennhauser, M.; Schluetermann, B.; Prasch, A.; Nehring, R. Gastro-resistant soft shell capsule and process for its manufacture. United States patent application US 14/900,002, 2016.
[7]
Jegorov, A.; Szrajber, R. Reduction of cross-linking gelatin in gelatin capsules. United States patent US 8,895,059, 2014.
[13]
Hassan, E.M.; Fatmi, A.A.; Chidambaram, N. Enteric composition for the manufacture of soft capsule wall. United States patent US 8,685,445, 2014.
[15]
Leiberich, R.; Gabler, W. Gastric juice resistant gelatin capsules and a process for the production thereof. United States patent US 3,959,540, 1976.
[16]
Aulton’s Pharmaceutics E-Book: The Design and Manufacture of
Medicines; Aulton, M.E.; Taylor, K.M., Eds.; Elsevier Health Sciences,
2017..
[17]
Deepak, G.; Kamal, K.; Ajay, B.; Mahesh, K.K. Soft gelatin capsules: development, applications and recent patents. IRJIPS, 2014, 2(3), 163-173.
[18]
Augsburger, LL Hard and soft gelatin capsules. Drugs and the pharmaceutical sciences, 1990, 40, 441-90.
[19]
Schwier, J.R.; Cooke, G.G.; Hartauer, K.J.; Yu, L. A reactive aldehyde capable of insolubilizing gelatin capsules. Pharm. Technol., 1993, 17(5), 78.
[20]
Taylor, S.K.; Davidson, F.; Ovenall, D.W. Carbon-13 nuclear magnetic resonance studies on gelatin crosslinking by formaldehyde. Photogr. Sci. Engng, 1978, 22(3), 134-138.
[26]
Clair, M.S.; Purdie, J.; Hu, Y.; McGeough, P. The Effect of Cross-Linking on theIn VitroDisintegration of Hard Gelatin Capsules. J. Pharm. Pharmacol., 2010, 62(10), 1235-1236.
[28]
Gallery, J; Han, JH; Abraham, C Pepsin and pancreatin performance in the dissolution of crosslinked gelatin capsules from pH 1 to 8. Pharm. Forum, 2004, 30(3), 1084-1089.
[30]
Aboul-Einien, M.H. Formulation and evaluation of felodipine in softgels with a solubilized core. Asian J Pharm Sci., 2009, 4(3), 144-160.
[32]
Hassan, E.M.; Fatmi, A.A.; Chidambaram, N. Enteric soft capsules. United States patent US 9,433,585, 2016.
[33]
Jain, D; Singh, S. Soft gelatin capsules: A review. Int. J. Pharm. Res., 2012, 2012(4), 07-16.
[34]
Humera, A; Jonathan, D; Jing, L. Enteric softgel capsules. Int. Appl. WO 2019/178481 A1, 2019.
[38]
Mhatre, R.M.; Malinowski, H.; Nguyen, H.; Meyer, M.C.; Straughn, A.B.; Lesko, L.; Williams, R.L. The effects of cross-linking in gelatin capsules on the bioequivalence of acetaminophen. Pharm. Res., 1997, 14(11), 3251.
[41]
Ratna, V; Devineni, J Formulation and evaluation of soft gelatin capsules of nelfinavir mesylate. Eur. J. Biomed. Pharm. Sci., 2016, 3(2), 398-407.